Room temperature susceptometry predicts biopsy determined hepatic iron in patients with elevated serum ferritin

FIND-CKD: a ran- domized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Bailie GR, Larkina M,

This weakness has motivated us to investigate in this direction and suggest an efficient solution to deal with this problem by proposing, to the best of our knowledge, the first

Discussion: The study will generate evidence as to whether screening serum ferritin in non-anemic pregnant women and replenishing their iron stores will likely reduce the

In this post-hoc analysis of the ISAACC study, we identified specific inflammatory and cardiovascular disease protein biomarkers associated with severe OSA in patients with a

In agreement with the observed changes in hepatic SREBP-1c expression in liver, central leptin blunted the up- regulation of the mRNA levels of ACC, FAS, and SCD-1 elicited by the

NSAIDs increase the risk of cardiovascular disease in the general population, and although there is little direct evidence for elevated cardiovascular risk with NSAIDs in people

Since AmrZ has been shown to be a global motility and iron regulator in F113, the 159 genes putatively regulated by FleQ in this strain were compared with the 215 genes found to

We know that patients with kidney disease have elevated serum levels of BPA and that some of the effects of BPA in laboratory ani- mals also appear in uraemic patients on